logo
Trump's trade deal with the EU: What it means for your wallet

Trump's trade deal with the EU: What it means for your wallet

Yahoo29-07-2025
Imported cars, pharmaceuticals, apparel and more could grow more expensive in the months to come as the United States imposes a 15% tariff on most imports from the European Union.
Analysts have labeled the agreement, announced July 27, as a win for President Donald Trump, whose administration had been working to complete deals by a self-imposed Aug. 1 deadline. U.S. stocks opened mostly higher on July 28, with the S&P 500 and Nasdaq reaching record highs after Trump announced a tariff far below the 30% rate threatened earlier in the month.
But for U.S. consumers, even the reduced tariff is expected to spur higher prices. The Yale Budget Lab estimates that Trump's tariffs, including the new rate for EU imports, would raise prices by 1.8% in the short run, the equivalent of an average household income loss of roughly $2,400.
While the increase may sound insignificant, 'the Federal Reserve's inflation target is 2%. So we're talking about almost a year's worth of inflation above and beyond the inflation that we would've gotten anyways,' said Ernie Tedeschi, director of economics at the Yale Budget Lab. 'So that's meaningful.'
Here are some of the sectors that could see higher prices in the months to come.
European cars
Automobiles, one of the EU's largest export sectors, will likely see some of the most noticeable price hikes, according to Gary Hufbauer, a nonresident senior fellow at the Peterson Institute for International Economics.
While the 15% tariff is a relief from the current 27.5% rate, Hufbauer said the auto industry's margins are thin enough that EU companies won't want to absorb the higher cost.
'I suspect European auto prices sold in the U.S. will go up probably at least 10%,' he told USA TODAY.
German Association of the Automotive Industry President Hildegard Müller warned the 15% tariff could cost the German automotive industry 'billions annually.' Already, Volkswagen has trimmed its full-year sales forecast after reporting a $1.5 billion hit from tariffs over the first half of the year.
Automobile price hikes will likely vary across European makes and models, according to Tedeschi, since many already operate factories in North America. That means trade deals with Canada and Mexico could also influence pricing.
'Consumers should keep an eye out for rising prices for European car imports, but they should not assume that all European brands are going to go up in price because of how complicated the supply chain is,' he said, adding that he expects to see price increases tied to the new EU tariffs play out this summer and fall.
What were the EU tariffs before? What to know after trade deal
Furniture
Furniture is another sector that could get hit by tariffs, according to Stephen Brown, Capital Economics' deputy chief North America economist.
The Swedish company IKEA, for instance, relies on China, Poland, Italy, Germany and Sweden to supply 'the majority' of products, according to its website. The company did not immediately respond to a request for comment, but Inter IKEA ‒ which produces IKEA furniture ‒ told Reuters in November that just 10% of the products it sells in the U.S. are made in the region.
'Unless they find somewhere else to import from or move around their supply chain, furniture prices ... could see some effects,' Brown said.
Pharmaceuticals
While certain sectors like wine and spirits appear to still be under negotiation, EU Commission President Ursula von der Leyen said pharmaceuticals will be covered by the 15% tariff, with certain generic drugs not subject to tariffs.
The EU is behind about 60% of pharmaceutical imports to the U.S., according to Reuters, making them the largest European export to the U.S. by value.
But Brown noted that pharmaceutical companies may be able to more easily shift production to the U.S. compared to other industries. For instance, the Danish manufacturer behind the GLP-1s Wegovy and Ozempic, Novo Nordisk, already has a presence in North Carolina and has plans to expand.
'Although there could be some short-term price increases, those might not be as durable as they are for other products,' Brown said.
Additionally, consumers may not pick up on the industry's price hikes if their insurance covers the imported drug.
Luxury items
Luxury items like imported designer handbags and apparel could also see higher prices, as well as imported food.
'The difference between China and Europe, in terms of tariffs, is that the tariffs on China increase what people buy in Walmart and Target. The tariffs on European imports will mainly hit what people buy at Whole Foods and high-end retail stores,' said Hufbauer of the Peterson Institute for International Economics.
He noted that the companies behind luxury goods tend to have higher margins, though, and may be more willing to absorb some of the higher costs tied to tariffs.
Machinery
Machinery and appliances are also major exports from the EU, accounting for roughly 20% of U.S. imports from the EU in 2021, according to the Commerce Department. While consumers won't buy machinery directly, experts warn the higher prices could eventually trickle down as manufacturers adjust to higher costs.
'These are not necessarily products that immediately or directly impact the consumers, but they can indirectly affect consumers, especially after many years,' Tedeschi said.
This article originally appeared on USA TODAY: What Trump's EU trade deal means for your wallet
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

25 Stocks to Avoid in August, Historically
25 Stocks to Avoid in August, Historically

Yahoo

time3 minutes ago

  • Yahoo

25 Stocks to Avoid in August, Historically

Dollar Tree Inc (NASDAQ:DLTR) stock nabbed a record high of $116.51 yesterday after an overdue price-target hike from Bernstein to $109 from $86. However, despite a 54.5% year-to-date gain, the discount retailer is entering a period of historical bearishness. DLTR is one of the worst stocks to own in August, per Schaeffer's Senior Quantitative Analyst Rocky White. Per the table above that goes back 10 years, the equity averages a monthly loss of 8.2%, finishing the month lower 80% of the time over the past 10 years. This makes it the worst performer on the list, which also happens to feature sector peer Dollar General (DG). A comparable move would continue the recent consolidation pattern the shares have formed in the last few weeks. Other factors working against DLTR is the stock's 14-Day Relative Strength Index (RSI), firmly in "overbought" territory at 72. Also note the ascending trendline in the chart below, an area that has alternated between support and resistance since those April bottoms. With earnings not until September 10, options are an intriguing route. The equity's Schaeffer's Volatility Index (VIX) of 27% sits in the bottom percentile of its annual range, meaning options traders are pricing in low volatility expectations. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Pfizer CEO details talks with Trump administration on tariffs, Most Favored Nations pricing
Pfizer CEO details talks with Trump administration on tariffs, Most Favored Nations pricing

Yahoo

time3 minutes ago

  • Yahoo

Pfizer CEO details talks with Trump administration on tariffs, Most Favored Nations pricing

Pfizer (PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the COVID-19 pandemic when the two were in regular contact to help speed up vaccine production. That relationship, he said, has created a direct line to discuss some of the headwinds the company faces out of Washington, D.C. In his second term, Trump is targeting the drug industry for high prices and overseas production — threatening tariffs as high as 250% on imported drugs. But Bourla told Yahoo Finance he believes Trump and other officials in D.C. are having productive conversations with industry leaders about tariffs and drug pricing. "I think [Trump] is educated, of course he doesn't go into the details, it's not his job, but he understands the dynamics [of the industry]," Bourla said. When asked about the tariff threat, Bourla shared his understanding from his ongoing discussions. "I don't want to speak for the president, but what he said today, which was very important also, was that it would be a very small tariff in the first couple of years. And then he opened the window for a grace period. Because I had this discussion with him and I had this discussion with multiple other members of the administration," Bourla said. Read more: What Trump's tariffs mean for the economy and your wallet The industry is awaiting the results of an investigation by the administration into how those tariffs will be implemented — and Bourla said the devil will be in the details. Currently, more than 90% of prescriptions in the US are from generics, which are often the cheapest drug type. Branded drugs are often the most expensive and are largely produced in the US. But some early components of the manufacturing process, key chemicals known as active pharmaceutical ingredients (APIs), are often made overseas in Europe or Asia. That will be important to understand when the final ruling for the tariffs is made. "We need to understand if the API will dictate the country of origin, or where the final product is made," Bourla said. Pfizer is also one of the companies that received a letter from Trump last week detailing demands to reduce prices for Medicare and Medicaid enrollees to match the lowest price paid by developing nations, known as Most Favored Nations (MFN). The company is currently planning for the implementation of reduced prices, as well as working on how to mitigate negative impacts, Bourla said. "We are still discussing it with the president. ... The devil could be in the details in these stages," he said. Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, provider services, digital health, PBMs, and health policy and politics. That includes GLP-1s, of course. Follow Anjalee as AnjKhem on social media platforms X, LinkedIn, and Bluesky @AnjKhem. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Tariffs are denting profits, and maybe soon your portfolio
Tariffs are denting profits, and maybe soon your portfolio

Yahoo

time3 minutes ago

  • Yahoo

Tariffs are denting profits, and maybe soon your portfolio

The theme of the moment in financial markets is the resilience of US stock values. President Trump is imposing billions of dollars in new import taxes on US firms, yet the S&P 500 (^GSPC) index is up 26% from its April low and fresh off several record highs. Investors who shunned US assets just a few months ago are now aggressively buying. However, numerous warning signs have emerged during the second quarter earnings season as companies outline the ways Trump's tariffs are hurting profits, disrupting operations, and forcing price hikes onto consumers. Tariffs are not hitting every company, since they mainly affect goods, and many of America's top firms are service providers. But some analysts think the negative tariff effects are widespread enough to take the wind out of stocks soon. With second quarter earnings in for about two-thirds of S&P 500 companies, Yahoo Finance's Grace O'Donnell has identified more than four dozen large firms saying tariffs are impacting their businesses in some material way. Some are able to quantify the monetary effect on earnings. Others expect tariffs to hit their finances but aren't yet sure how. And some CEOs have been blunt about price hikes heading toward consumers. Manufacturers are bearing a large portion of the tariff cost, since many rely on imported components that are now more expensive. Caterpillar (CAT), Kimberly-Clark (KMB), BMW ( Ford (F), Harley-Davidson (HOG), Hyundai (HYMTF), Tesla (TSLA), GE Aerospace (GE), 3M (MMM), and General Motors (GM) are among the companies saying tariffs reduced earnings in the second quarter. Ford, as one example, said tariffs would knock $2 billion off earnings this year. Caterpillar expects a tariff hit of at least $1.3 billion. Kimberly-Clark's tariff loss will be around $170 million. Read more: The latest news and updates on Trump's tariffs It's not just manufacturers. Companies that import products they sell to consumers are suffering too. Apple (AAPL) expects tariffs to cut earnings by nearly $2 billion for the six months through Sept. 30. Hershey (HSY) said tariffs will cost it at least $170 million this year. VF Corp., whose brands include Vans, The North Face, and Timberland, sees a $250 million hit to earnings through 2026. Some of America's biggest consumer goods producers, including Procter & Gamble (PG), Mattel (MAT), Columbia Sportswear (COLM), and L'Oreal (LOR.F), say they'll have no choice but to pass some of their higher costs onto consumers. Many executives discussing the Trump tariffs say it's too soon to assess the impact of import taxes that have only been in place a couple of months, which means a lot more bad news may be in the pipeline. The disconnect in markets right now is that tariff impacts that are causing headline damage for a lot of individual companies don't yet seem to be depressing overall earnings. Roughly 80% of companies reporting their earnings so far have beaten analyst estimates, according to FactSet. That's better than the usual beat ratio. Earnings growth has also been solid, and Wall Street forecasts for the third quarter are even better, despite the tariffs. Solid actual earnings and robust forecasts for future gains are the driving forces motivating investors to buy. Read more: 5 ways to tariff-proof your financesThe question is will it last, and there are several reasons for doubt. Oxford Economics thinks investors are too bullish now because they were too panicky in April and May, when Trump imposed dramatically high tariffs that he has since lowered. Trump's "Liberation Day" tariff announcements on April 2 triggered a big stock sell-off, which in turn prompted Trump to back down and pause some of those tariffs. The average tariff rate jumped from 2.5% before Trump took office to about 28% after "Liberation Day." Recent changes to Trump's tariff regime brought the average import tax to as low as 14%, then up to about 18%, where it is today. So, the average import tax is now lower than it was in April and May — but still considerably higher than it's been for the past 90 years. That will still sting. "Margin resilience [is] unlikely to last," Oxford economists noted in an Aug. 5 analysis. "We think margin pressures will build throughout the second half of the year as the effective tariff rate continues to move higher, businesses deplete front-run inventories, and domestic demand softens." Bloomberg recently reported that several Wall Street money managers, including Morgan Stanley, Evercore ISI, and Deutsche Bank, are warning clients that a stock pullback of 10% to 15% could be on the horizon. Trump's trade wars are the biggest concern, as the rising toll of import taxes further damages profits, raises prices, reins in spending, and depresses growth. The sharp slowdown in job growth during the past three months may be a harbinger of worse to come. The average pace of job gains from May through July was just 35,000, an 80% decline from the 2024 pace. Trump got so angry over those numbers that he fired the government economist who oversees the employment report. But the real problem is Trump's own policies, and he can't fire every CEO who needs to explain how tariffs are harming profits. Rick Newman is a senior columnist for Yahoo Finance. Follow him on Bluesky and X: @rickjnewman. Click here for political news related to business and money policies that will shape tomorrow's stock prices.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store